Nucor Corp has a consensus price target of $169.59 based on the ratings of 18 analysts. The high is $240 issued by Citigroup on March 13, 2024. The low is $114 issued by Goldman Sachs on October 6, 2022. The 3 most-recent analyst ratings were released by JP Morgan, B of A Securities, and BMO Capital on July 16, 2024, June 26, 2024, and June 17, 2024, respectively. With an average price target of $181.67 between JP Morgan, B of A Securities, and BMO Capital, there's an implied 12.29% upside for Nucor Corp from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/16/2024 | Buy Now | 5.08% | JP Morgan | Bill Peterson | $180 → $170 | Maintains | Neutral | Get Alert |
06/26/2024 | Buy Now | 23.62% | B of A Securities | Lawson Winder | $210 → $200 | Maintains | Buy | Get Alert |
06/17/2024 | Buy Now | 8.17% | BMO Capital | Katja Jancic | $185 → $175 | Maintains | Market Perform | Get Alert |
06/11/2024 | Buy Now | 11.26% | JP Morgan | Bill Peterson | $190 → $180 | Maintains | Neutral | Get Alert |
05/20/2024 | Buy Now | 17.44% | Jefferies | Christopher LeFemina | → $190 | Initiates | → Hold | Get Alert |
04/24/2024 | Buy Now | 23.62% | BMO Capital | Katja Jancic | $210 → $200 | Maintains | Market Perform | Get Alert |
04/24/2024 | Buy Now | 17.44% | JP Morgan | Bill Peterson | $195 → $190 | Maintains | Neutral | Get Alert |
04/16/2024 | Buy Now | 20.53% | JP Morgan | Bill Peterson | $180 → $195 | Maintains | Neutral | Get Alert |
03/13/2024 | Buy Now | 48.35% | Citigroup | Alexander Hacking | $180 → $240 | Upgrade | Neutral → Buy | Get Alert |
01/16/2024 | Buy Now | 29.81% | UBS | Curt Woodworth | → $210 | Initiates | → Buy | Get Alert |
12/12/2023 | Buy Now | -2.34% | JP Morgan | Bill Peterson | $151 → $158 | Maintains | Neutral | Get Alert |
10/31/2023 | Buy Now | -4.81% | Morgan Stanley | Carlos De Alba | $162 → $154 | Maintains | Equal-Weight | Get Alert |
10/16/2023 | Buy Now | -6.66% | JP Morgan | Michael Glick | → $151 | Upgrade | Underweight → Neutral | Get Alert |
09/08/2023 | Buy Now | -6.66% | JP Morgan | Michael Glick | $150 → $151 | Maintains | Underweight | Get Alert |
07/27/2023 | Buy Now | 11.26% | Citigroup | Alexander Hacking | $160 → $180 | Maintains | Neutral | Get Alert |
07/26/2023 | Buy Now | 0.14% | Morgan Stanley | Carlos De Alba | $148 → $162 | Maintains | Equal-Weight | Get Alert |
07/11/2023 | Buy Now | 3.23% | Credit Suisse | Curt Woodworth | $156 → $167 | Maintains | Outperform | Get Alert |
07/05/2023 | Buy Now | 18.06% | Exane BNP Paribas | Seth Rosenfeld | → $191 | Upgrade | Neutral → Outperform | Get Alert |
06/21/2023 | Buy Now | -8.52% | Morgan Stanley | Carlos De Alba | → $148 | Reiterates | → Equal-Weight | Get Alert |
06/01/2023 | Buy Now | — | Wolfe Research | Timna Tanners | — | Upgrade | Underperform → Peer Perform | Get Alert |
05/23/2023 | Buy Now | -19.64% | JP Morgan | Michael Glick | → $130 | Initiates | → Underweight | Get Alert |
05/22/2023 | Buy Now | -8.52% | Morgan Stanley | Carlos De Alba | $133 → $148 | Maintains | Equal-Weight | Get Alert |
04/24/2023 | Buy Now | -17.79% | Morgan Stanley | Carlos De Alba | $131 → $133 | Maintains | Equal-Weight | Get Alert |
03/20/2023 | Buy Now | -19.03% | Morgan Stanley | Carlos De Alba | $122 → $131 | Maintains | Equal-Weight | Get Alert |
03/17/2023 | Buy Now | -3.57% | Credit Suisse | Curt Woodworth | $140 → $156 | Maintains | Outperform | Get Alert |
03/13/2023 | Buy Now | -0.48% | Goldman Sachs | Kate McShane | $144 → $161 | Maintains | Neutral | Get Alert |
03/10/2023 | Buy Now | -0.48% | Goldman Sachs | Kate McShane | $144 → $161 | Maintains | Neutral | Get Alert |
01/30/2023 | Buy Now | -24.59% | Morgan Stanley | Carlos De Alba | $113 → $122 | Maintains | Equal-Weight | Get Alert |
01/27/2023 | Buy Now | 1.99% | BMO Capital | David Gagliano | $155 → $165 | Maintains | Market Perform | Get Alert |
01/04/2023 | Buy Now | 6.32% | B of A Securities | Lawson Winder | → $172 | Reinstates | → Buy | Get Alert |
12/06/2022 | Buy Now | -10.37% | UBS | Andreas Bokkenheuser | $120 → $145 | Maintains | Neutral | Get Alert |
11/09/2022 | Buy Now | -12.23% | BMO Capital | David Gagliano | $113 → $142 | Maintains | Market Perform | Get Alert |
10/24/2022 | Buy Now | -30.15% | Morgan Stanley | Carlos De Alba | $115 → $113 | Maintains | Equal-Weight | Get Alert |
10/06/2022 | Buy Now | -29.53% | Goldman Sachs | Emily Chieng | $127 → $114 | Maintains | Neutral | Get Alert |
09/16/2022 | Buy Now | -13.46% | Credit Suisse | Curt Woodworth | $165 → $140 | Maintains | Outperform | Get Alert |
07/25/2022 | Buy Now | -28.92% | Morgan Stanley | Carlos De Alba | $121 → $115 | Maintains | Equal-Weight | Get Alert |
07/06/2022 | Buy Now | -25.21% | Morgan Stanley | Carlos De Alba | $144 → $121 | Maintains | Equal-Weight | Get Alert |
06/14/2022 | Buy Now | -22.73% | JP Morgan | Michael Glick | $146 → $125 | Maintains | Neutral | Get Alert |
05/31/2022 | Buy Now | -19.64% | Goldman Sachs | Emily Chieng | $148 → $130 | Maintains | Neutral | Get Alert |
05/11/2022 | Buy Now | -10.99% | Morgan Stanley | Carlos De Alba | $108 → $144 | Maintains | Equal-Weight | Get Alert |
04/25/2022 | Buy Now | 17.44% | Argus Research | David Coleman | $140 → $190 | Maintains | Buy | Get Alert |
04/22/2022 | Buy Now | -8.52% | Goldman Sachs | Emily Chieng | $134 → $148 | Maintains | Neutral | Get Alert |
04/22/2022 | Buy Now | 8.17% | Credit Suisse | Curt Woodworth | $142 → $175 | Maintains | Outperform | Get Alert |
03/24/2022 | Buy Now | -20.26% | JP Morgan | Michael Glick | $113 → $129 | Maintains | Neutral | Get Alert |
02/16/2022 | Buy Now | -25.83% | Goldman Sachs | Emily Chieng | $114 → $120 | Maintains | Neutral | Get Alert |
01/31/2022 | Buy Now | -33.24% | Morgan Stanley | Carlos De Alba | $107 → $108 | Maintains | Equal-Weight | Get Alert |
01/11/2022 | Buy Now | -36.95% | Wolfe Research | Timna Tanners | → $102 | Downgrade | Peer Perform → Underperform | Get Alert |
11/17/2021 | Buy Now | -35.72% | Wolfe Research | Timna Tanners | — | Initiates | → Peer Perform | Get Alert |
10/26/2021 | Buy Now | -33.86% | Morgan Stanley | Carlos De Alba | — | Maintains | Equal-Weight | Get Alert |
10/06/2021 | Buy Now | -33.24% | Goldman Sachs | Emily Chieng | — | Downgrade | Buy → Neutral | Get Alert |
09/15/2021 | Buy Now | -19.64% | Deutsche Bank | Chris Terry | — | Maintains | Hold | Get Alert |
08/24/2021 | Buy Now | -19.64% | Seaport Global | Martin Englert | — | Initiates | → Buy | Get Alert |
The latest price target for Nucor (NYSE:NUE) was reported by JP Morgan on July 16, 2024. The analyst firm set a price target for $170.00 expecting NUE to rise to within 12 months (a possible 5.08% upside). 16 analyst firms have reported ratings in the last year.
The latest analyst rating for Nucor (NYSE:NUE) was provided by JP Morgan, and Nucor maintained their neutral rating.
The last upgrade for Nucor Corp happened on March 13, 2024 when Citigroup raised their price target to $240. Citigroup previously had a neutral for Nucor Corp.
The last downgrade for Nucor Corp happened on January 11, 2022 when Wolfe Research changed their price target from N/A to $102 for Nucor Corp.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Nucor, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Nucor was filed on July 16, 2024 so you should expect the next rating to be made available sometime around July 16, 2025.
While ratings are subjective and will change, the latest Nucor (NUE) rating was a maintained with a price target of $180.00 to $170.00. The current price Nucor (NUE) is trading at is $161.78, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.